P&G Acquires Thorne in $3.8B Wellness Deal

Jackson Turner 08/05/2026

The Wellness Revolution: Procter & Gamble Acquires Science-Backed Thorne in Multi-Billion Dollar Deal

In a strategic move to dominate the future of consumer health, Procter & Gamble has agreed to acquire the science-backed wellness brand Thorne from investment firm L Catterton in a massive US$3.8 billion cash transaction. This landmark deal signals a major shift in how massive consumer goods corporations are approaching the booming wellness sector, emphasizing the growing demand for preventative health and personalized nutrition.

The acquisition is more than just a purchase; it is an investment in a specific type of product—one rooted deeply in clinical support and rigorous science. Thorne, which specializes in vitamins, minerals, and supplements, has built a strong reputation by blending high-quality formulation with practical health advice.

The deal builds on a foundation of strategic partnership. Prior to the acquisition, L Catterton had invested in Thorne back in 2023, actively supporting the brand’s expansion across several critical areas. This support focused heavily on advancing the brand through increased investment in research and development, manufacturing capabilities, digital platforms, and the integration of advanced technology.

During that partnership, Thorne focused on strengthening its practitioner relationships, establishing a trusted connection with healthcare professionals who advocate for evidence-based supplementation. Crucially, they also developed a proprietary AI wellness advisor, demonstrating an early commitment to leveraging artificial intelligence to deliver personalized nutritional guidance to consumers.

By bringing Thorne into the fold, P&G is positioning itself at the forefront of this evolving market. The move underscores the growing realization among major consumer goods companies that the future of retail success lies not just in traditional goods, but in clinically supported supplements and personalized health solutions.

This acquisition reflects a broader industry trend: the intense focus on preventative health has driven consumers to seek out supplements that offer verifiable results rather than simple marketing promises. Companies like P&G are recognizing that capital investment in science-backed wellness brands is essential for capitalizing on this rising demand for personalized nutrition.

With the transaction anticipated to close in the fourth quarter of 2026, the integration of Thorne‘s scientific rigor and digital capabilities into P&G’s vast operational framework is set to redefine what it means to be a major player in the health and wellness landscape. It is a powerful demonstration that the intersection of consumer goods and cutting-edge science is where the next wave of growth will happen.